Literature DB >> 17620444

HDL composition predicts new-onset cardiovascular disease in patients with type 1 diabetes.

Per-Henrik Groop1, Merlin C Thomas, Milla Rosengård-Bärlund, Vashti Mills, Mats Rönnback, Stephen Thomas, Carol Forsblom, Maria-Rita Taskinen, Giancarlo Viberti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17620444     DOI： 10.2337/dc07-0030

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  11 in total

Review 1.  Cardiovascular disease risk in young people with type 1 diabetes.

Authors:  Janet K Snell-Bergeon; Kristen Nadeau
Journal:  J Cardiovasc Transl Res       Date:  2012-04-12       Impact factor: 4.132

2.  Increased Risk of Obesity and Metabolic Dysregulation Following 12 Months of Second-Generation Antipsychotic Treatment in Children: A Prospective Cohort Study.

Authors:  Rebecca Ronsley; Duc Nguyen; Jana Davidson; Constadina Panagiotopoulos
Journal:  Can J Psychiatry       Date:  2015-10       Impact factor: 4.356

3.  Lower levels of total HDL and HDL3 cholesterol are associated with albuminuria in normoalbuminuric Type 1 diabetic patients.

Authors:  T Bulum; B Kolaric; L Duvnjak
Journal:  J Endocrinol Invest       Date:  2013-02-12       Impact factor: 4.256

4.  Lipid abnormalities predict progression of renal disease in patients with type 1 diabetes.

Authors:  N Tolonen; C Forsblom; L Thorn; J Wadén; M Rosengård-Bärlund; M Saraheimo; M Feodoroff; V-P Mäkinen; D Gordin; M-R Taskinen; P-H Groop
Journal:  Diabetologia       Date:  2009-10-10       Impact factor: 10.122

Review 5.  Mass Spectrometry-Based Proteomic Study Makes High-Density Lipoprotein a Biomarker for Atherosclerotic Vascular Disease.

Authors:  Chiz-Tzung Chang; Chao-Yuh Yang; Fuu-Jen Tsai; Shih-Yi Lin; Chao-Jung Chen
Journal:  Biomed Res Int       Date:  2015-05-18       Impact factor: 3.411

6.  Proteomic alterations of HDL in youth with type 1 diabetes and their associations with glycemic control: a case-control study.

Authors:  Evgenia Gourgari; Junfeng Ma; Martin P Playford; Nehal N Mehta; Radoslav Goldman; Alan T Remaley; Scott M Gordon
Journal:  Cardiovasc Diabetol       Date:  2019-03-28       Impact factor: 9.951

7.  Network of vascular diseases, death and biochemical characteristics in a set of 4,197 patients with type 1 diabetes (the FinnDiane Study).

Authors:  Ville-Petteri Mäkinen; Carol Forsblom; Lena M Thorn; Johan Wadén; Kimmo Kaski; Mika Ala-Korpela; Per-Henrik Groop
Journal:  Cardiovasc Diabetol       Date:  2009-10-06       Impact factor: 9.951

8.  Pharmacogenomic application of the haptoglobin genotype in the treatment of HDL dysfunction.

Authors:  Avery Schwartz; Shany Blum; Rabea Asleh; Mordechai Pollak; Shiri Kalet-Litman; Andrew P Levy
Journal:  Pharmgenomics Pers Med       Date:  2009-02-27

9.  Metabolic phenotypes, vascular complications, and premature deaths in a population of 4,197 patients with type 1 diabetes.

Authors:  Ville-Petteri Mäkinen; Carol Forsblom; Lena M Thorn; Johan Wadén; Daniel Gordin; Outi Heikkilä; Kustaa Hietala; Laura Kyllönen; Janne Kytö; Milla Rosengård-Bärlund; Markku Saraheimo; Nina Tolonen; Maija Parkkonen; Kimmo Kaski; Mika Ala-Korpela; Per-Henrik Groop
Journal:  Diabetes       Date:  2008-06-10       Impact factor: 9.461

10.  Effects of the Particulate Matter₂.₅ (PM₂.₅) on Lipoprotein Metabolism, Uptake and Degradation, and Embryo Toxicity.

Authors:  Jae-Yong Kim; Eun-Young Lee; Inho Choi; Jihoe Kim; Kyung-Hyun Cho
Journal:  Mol Cells       Date:  2015-11-26       Impact factor: 5.034
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.